The Cancer Support Community’s VP of Education & Outreach, Claire Saxton, MBA, talks with multiple myeloma specialist Saad Z. Usmani, MD, MBA, FACP, about the effects of COVID-19 on blood cancer patients. Dr. Usmani is the Director of Clinical Research in Hematologic Malignancies in the Department of Hematologic Oncology & Blood Disorders at the Levine Cancer Institute in Charlotte, North Carolina. They discuss how COVID-19 has impacted blood cancer treatment and common concerns about the COVID-19 vaccine from blood cancer patients, including multiple myeloma.